Search

Your search keyword '"Miyakawa, Kei"' showing total 232 results

Search Constraints

Start Over You searched for: Author "Miyakawa, Kei" Remove constraint Author: "Miyakawa, Kei"
232 results on '"Miyakawa, Kei"'

Search Results

4. Rapid and Safe Neutralization Assay for Circulating H5N1 Influenza Virus in Dairy Cows.

5. MARCH8 Restricts RSV Replication by Promoting Cellular Apoptosis Through Ubiquitin-Mediated Proteolysis of Viral SH Protein.

12. A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron

13. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests

17. Development of a contacting transwell co-culture system for the in vitro propagation of primary central nervous system lymphoma

24. Prospective Clinical Evaluation of the Diagnostic Accuracy of a Highly Sensitive Rapid Antigen Test Using Silver Amplification Technology for Emerging SARS-CoV-2 Variants

25. Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy

26. Development of a Fully Automated Desktop Analyzer and Ultrahigh Sensitivity Digital Immunoassay for SARS-CoV-2 Nucleocapsid Antigen Detection

29. Development of Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of Human Norovirus Major Capsid Protein

30. Inhibition of nonhomologous end joining‐mediated DNA repair enhances anti‐HBV CRISPR therapy

31. Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice

32. Intratracheal trimerized nanobody cocktail protects against SARS-CoV-2 Omicron in mice

38. Establishment of monoclonal antibodies broadly neutralize infection of hepatitis B virus

41. Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection

42. Enhancement of Humoral and Cellular Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 by a Third Dose of BNT162b2 Vaccine in Japanese Healthcare Workers.

45. Nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants

46. Persistence of robust humoral immune response in COVID-19 convalescent individuals over 12 months after infection

47. Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay

50. Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus–Infected Hepatocytes During Interferon Administration

Catalog

Books, media, physical & digital resources